Consensus on Contouring Primary Breast Tumors on MRI in the Setting of Neoadjuvant Partial Breast Irradiation in Trials

Autor: Vasmel, Jeanine E., Groot Koerkamp, Maureen L., Kirby, Anna M., Russell, Nicola S., Shaitelman, Simona F., Vesprini, Danny, Anandadas, Carmel N., Currey, Adam, Keller, Brian M., Braunstein, Lior Z., Han, Kathy, Kotte, Alexis N.T.J., de Waard, Stephanie N., Philippens, Marielle E.P., Houweling, Antonetta C., Verkooijen, Helena M., van den Bongard, H.J.G. Desiree

Publikováno v: In Practical Radiation Oncology November-December 2020 10(6):e466-e474

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Biochemical and biophysical characterization of the nucleic acid binding properties of the RNA / DNA binding protein EWS

Autor: Emily E. Selig, Roohi Bhura, Matthew R. White, Shivani Akula, Renee D. Hoffman, Carmel N. Tovar, Xiaoping Xu, Rachell E. Booth, David S. Libich

Publikováno v: Biopolymers. 114

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23817df006588ad144cedf519857b3c4
https://doi.org/10.1002/bip.23536

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Selection criteria for early breast cancer patients in the DBCG proton trial - The randomised phase III trial strategy

Autor: Henrik Nissen, Youlia M. Kirova, Karen Andersen, S. Hol, K. Verhoeven, L.B. Stick, Cynthia Aristei, Johan Vikström, Livia Marrazzo, Angela Matías-Pérez, Birgitte Vrou Offersen, Orla Byrne, Ingelise Jensen, Mette Marie Bruun Nielsen, Carmel N Anandadas, Sileida Oliveros, E.S. Yates, Anna M. Kirby, Ebbe Laugaard Lorenzen

Publikováno v: Clinical and Translational Radiation Oncology, 27, 126-131. Elsevier Ireland Ltd
Stick, L B, Lorenzen, E L, Yates, E S, Anandadas, C, Andersen, K, Aristei, C, Byrne, O, Hol, S, Jensen, I, Kirby, A M, Kirova, Y M, Marrazzo, L, Matías-Pérez, A, Nielsen, M M B, Nissen, H D, Oliveros, S, Verhoeven, K, Vikström, J & Offersen, B V 2021, ' Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy ', Clinical and Translational Radiation Oncology, vol. 27, pp. 126-131 . https://doi.org/10.1016/j.ctro.2021.01.012
Stick, L B, Lorenzen, E L, Yates, E S, Anandadas, C, Andersen, K, Aristei, C, Byrne, O, Hol, S, Jensen, I, Kirby, A M, Kirova, Y M, Marrazzo, L, Matías-Pérez, A, Nielsen, M M B, Nissen, H D, Oliveros, S, Verhoeven, K, Vikström, J & Offersen, B V 2021, ' Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy ', Clinical and translational radiation oncology, vol. 27, pp. 126-131 . https://doi.org/10.1016/j.ctro.2021.01.012
Stick, L B, Lorenzen, E L, Yates, E S, Anandadas, C, Andersen, K, Aristei, C, Byrne, O, Hol, S, Jensen, I, Kirby, A M, Kirova, Y M, Marrazzo, L, Matias-Perez, A, Nielsen, M M B, Nissen, H D, Oliveros, S, Verhoeven, K, Vikstrom, J & Offersen, B V 2021, ' Selection criteria for early breast cancer patients in the DBCG proton trial-The randomised phase III trial strategy ', Clinical and Translational Radiation Oncology, vol. 27, pp. 126-131 . https://doi.org/10.1016/j.ctro.2021.01.012
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 126-131 (2021)

Highlights • We establish selection criteria for the randomised DBCG Proton Trial. • DBCG proton selection criteria: mean heart dose ≥ 4 Gy and/or lung V17Gy/V20Gy ≥ 37%. • ~1 in 5 patients undergoing loco-regional radiotherapy will be elig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ab4e6c34d01e5346ed170802b071df
https://cris.maastrichtuniversity.nl/en/publications/edd7f490-5dba-40e4-9a3a-59aca6ce3e57